Tim1 Deficiency Mediates Gestational Hyperglycemia-Related Syncytiotrophoblast Dysfunction and Fetal Growth...

Area of Science:

• Obstetrics and Gynecology
• Developmental Biology
• Metabolic Disorders

Background:

• Gestational hyperglycemia (GHG) is a known cause of fetal growth restriction (FGR).
• The underlying mechanisms, particularly placental dysfunction, are not fully understood.
• Defects in the syncytiotrophoblast, crucial for nutrient exchange, are implicated in FGR.

Purpose of the Study:

• To investigate the role of syncytiotrophoblast dysfunction in GHG-induced FGR.
• To identify molecular mechanisms linking GHG to placental defects and FGR.
• To explore potential therapeutic targets for GHG-related FGR.

Main Methods:

• Utilized a streptozotocin (STZ)-induced GHG mouse model.
• Employed immunofluorescence, transmission electron microscopy, and gene expression profiling.
• Conducted in vitro studies with trophoblast cells and generated Tim1 knockout mice.

Main Results:

• GHG led to FGR, reduced placental efficiency, and defective syncytiotrophoblast formation due to impaired trophoblast fusion.
• Tim1, a phosphatidylserine-binding protein, was downregulated in GHG placentas and in vitro.
• Tim1 deficiency alone caused FGR; its downregulation was linked to oxidative stress, and antioxidant treatment improved FGR.
• Reduced TIM1 expression was also observed in human placentas from pregnancies with diabetes and FGR.

Conclusions:

• Tim1 downregulation contributes to syncytiotrophoblast formation defects and FGR in gestational hyperglycemia.
• Oxidative stress plays a role in Tim1 downregulation during GHG.
• Tim1 represents a potential therapeutic target for managing FGR in pregnancies complicated by hyperglycemia.